To assess the in vivo significance of dysadherin in HCC, we employed a humanized mouse model (Hu-NSG-SGM3) reconstituted with human CD34+ hematopoietic stem cells (Fig. 6a). Here, FXYD5 is linked to hepatocellular carcinoma.